Evidence map›Paper›PMID 40616685›Full record

ArticleActa diabetologica2025

The impact of short maternal height on gestational diabetes.

Joan Crane, Phil Murphy, Donnette O'Brien

Abstract read
PubMed Publisher
In one paragraph

Article in Acta diabetologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joan CraneDepartment of Obstetrics and Gynecology, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada. joan.crane@icloud.com.ORCID http://orcid.org/0000-0002-0289-500X
Phil MurphyNewfoundland and Labrador Health Services, St. John's, NL, Canada.
Donnette O'BrienNewfoundland and Labrador Health Services, St. John's, NL, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo evaluate the impact of short maternal height on gestational diabetes, by different body mass index (BMI) classes.

methodsWe performed this population-based retrospective cohort study including individuals with singleton pregnancies delivering January 1st 2012 to December 31st 2019 in the Eastern Health region of the province of Newfoundland and Labrador, Canada. We divided maternal height into three groups: < 25% (short height), 25-75% (average height), and > 75% (tall height). We performed univariate and multivariate regression analyses (adjusting for potential confounders identified in univariate analyses) to determine if short height was an independent predictor of gestational diabetes, stratified by BMI class.

resultsWe assessed 15,803 pregnancies, with 1062 (6.7%) experiencing gestational diabetes. Among all BMI categories combined, short height was an independent predictor of gestational diabetes (OR = 1.20, 95% CI 1.02-1.41, p = 0.031). In stratified analyses, short height was an independent predictor of gestational diabetes among those with a normal BMI (OR = 1.75, 95% CI 1.23-2.50, p = 0.002) but not an independent predictor in higher BMI classes.

conclusionsThe association between short maternal height and gestational diabetes varies by BMI class. Among those with a normal BMI, short maternal height is associated with the development of gestational diabetes.

Indexed as

Body HeightDiabetes, GestationalAdultBody Mass IndexFemaleHumansNewfoundland and LabradorPregnancyRetrospective StudiesRisk FactorsBody mass indexDiabetes, gestationalMaternal heightPregnancyStature

Identifiers

PMID40616685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.